Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Shanghai Pharma to Sign Contracts with Pfizer, Sanofi-Aventis
Bloomberg
Tuesday, April 12, 2011 - 9:22am
tags:
Pfizer, Sanofi, Shanghai Pharmaceutical, China, Novo Nordisk
DUSA: A Pharmaceutical With Profits Now and Strong Growth Ahead
Seeking Alpha
Monday, April 11, 2011 - 6:48pm
tags:
DUSA pharmaceuticals, Levulan photodynamic therapy
Durect pain patch Eladur fails in midstage study on chronic lower back pain
Yahoo/AP
Monday, April 11, 2011 - 6:46pm
tags:
Eladur, pain patches, Durect Corporation
Pfizer’s Lyrica Tops Drugs Recommended for Diabetes Nerve Pain
Bloomberg
Monday, April 11, 2011 - 6:45pm
tags:
Pfizer, Lyrica, diabetes, nerve pain
A Double Dose of Trouble for Big Pharma?
Motley Fool
Monday, April 11, 2011 - 5:00pm
tags:
Pfizer, Novartis, Afinitor, Sutent, pancreatic tumors
Vertex Pharmaceuticals: Telaprevir a Likely Lock for Approval
Seeking Alpha
Monday, April 11, 2011 - 2:29pm
tags:
hepatitis C, Vertex Pharmaceuticals, Telaprevir, Dendreon, Forest Labs, Orexigen
Valeant could raise Cephalon bid if it saw books
Reuters
Monday, April 11, 2011 - 12:50pm
tags:
Valeant Pharmaceuticals, Cephalon, M&A
Amgen beefs up in Brazil with $215M deal
Fierce Pharma
Monday, April 11, 2011 - 12:49pm
tags:
Amgen, Brazil, Bergamo, M&A
Endo to Buy American Medical for $2.9 Billion to Trim Pain-Drug Dependence
Bloomberg
Monday, April 11, 2011 - 12:41pm
tags:
M&A, incontinence, American Medical Systems, Endo
Yet Another Step Back For MannKind
Pharmalot
Monday, April 11, 2011 - 12:40pm
tags:
diabetes, MannKind, inhaled insulin, Afrezza
Novartis ends Tasigna trial in intestinal cancer
Yahoo/AP
Monday, April 11, 2011 - 12:39pm
tags:
Novartis, Tasigna, intestinal cancer
Impax challenges Oxycontin patents, faces lawsuit
Yahoo/AP
Monday, April 11, 2011 - 12:17pm
tags:
Impax, patents, oxycontin, painkillers
Approval In Hand, Does Xenoport Have The Legs To Run?
Investopedia
Monday, April 11, 2011 - 12:16pm
tags:
restless legs syndrome, XenoPort, GSK, Horizant
Lost flu sales weigh on Roche and other pharmas in Q1
Yahoo/AP
Monday, April 11, 2011 - 12:09pm
tags:
Roche, earnings, AstraZeneca, Bristol-Myers Squibb, Flu, Abbott Laboratories
Why Provenge Could Be a $10 Billion Drug for Dendreon
Seeking Alpha
Monday, April 11, 2011 - 11:44am
tags:
Provenge, prostate cancer, Dendreon, vaccines
Biogen Idec MS drug meets goal in late-stage study
Yahoo/AP
Monday, April 11, 2011 - 11:43am
tags:
Biogen Idec, MS, BG-12, multiple sclerosis
Qnexa Trial Data is Good News for Vivus as Stock Rises
WSJ Online
Monday, April 11, 2011 - 11:42am
tags:
Qnexa, Vivus, obesity
Doctors Are Losing Faith In Johnson & Johnson
Pharmalot
Monday, April 11, 2011 - 11:39am
tags:
physicians, JNJ, doctors
Intercell, Merck’s V710 ‘Showed Some Benefit,’ Zettlmeissl Says
Bloomberg
Monday, April 11, 2011 - 11:38am
tags:
MRSA, vaccines, V710, Merck, Intercell, hospital infections
Medivation/Pfizer drug fails late-stage Huntington's disease trial
Bizjournals.com
Monday, April 11, 2011 - 11:36am
tags:
Huntington's disease, Pfizer, Medivation, dimebon

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.